Center-Authored Papers

Filters: Keyword is Follow-Up Studies  [Clear All Filters]
A
Agalliu I, Costello S, Applebaum KM, Ray RM, Astrakianakis G, Gao D, Thomas DB, Checkoway H, Eisen EA.  2011.  Risk of lung cancer in relation to contiguous windows of endotoxin exposure among female textile workers in Shanghai.. Cancer causes & control : CCC. 22(10):1397-1404. Abstract
Allan EJ, Flowers MED, Lin MP, Bensinger RE, Martin PJ, Wu MC.  2011.  Visual acuity and anterior segment findings in chronic graft-versus-host disease.. Cornea. 30(12):1392-7. Abstract
Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring WM, Robison LL, Mertens AC.  2009.  Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(14):2328-38. Abstract
Au DH, Bryson CL, Chien JW, Sun H, Udris EM, Evans LE, Bradley KA.  2009.  The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations.. Journal of general internal medicine. 24(4):457-63. Abstract
Austin PF, Cruse CW, Lyman G, Schroer K, Glass F, Reintgen DS.  1994.  Age as a prognostic factor in the malignant melanoma population.. Annals of surgical oncology. 1(6):487-94. Abstract
B
Baker KS, Bresters D, Sande JE.  2010.  The burden of cure: long-term side effects following hematopoietic stem cell transplantation (HSCT) in children.. Pediatric clinics of North America. 57(1):323-42. Abstract
Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, Cholerton BA, Plymate SR, Fishel MA, Watson SG et al..  2010.  Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease.. Journal of Alzheimer's disease : JAD. 22(2):569-79. Abstract
Baljevic M, Dumitriu B, Lee J-W, Paietta EM, Wiernik PH, Racevskis J, Chen C, Stein EM, Gallagher RE, Rowe JM et al..  2016.  Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia.. Acta haematologica. 136(4):210-218. Abstract
Ballard-Barbash R, Hunsberger S, Alciati MH, Blair SN, Goodwin PJ, McTiernan A, Wing R, Schatzkin A.  2009.  Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations.. Journal of the National Cancer Institute. 101(9):630-43. Abstract
Barlogie B, Attal M, Crowley J, van Rhee F, Szymonifka J, Moreau P, Durie BGM, Harousseau J-L.  2010.  Long-term follow-up of autotransplantation trials for multiple myeloma: update of protocols conducted by the intergroupe francophone du myelome, southwest oncology group, and university of arkansas for medical sciences.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(7):1209-14. Abstract
Barlogie B, Anaissie E, van Rhee F, Shaughnessy JD, Szymonifka J, Hoering A, Petty N, Crowley J.  2010.  Reiterative survival analyses of total therapy 2 for multiple myeloma elucidate follow-up time dependency of prognostic variables and treatment arms.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(18):3023-7. Abstract
Basinski JR, Alfano CM, Katon WJ, Syrjala KL, Fann JR.  2010.  Impact of delirium on distress, health-related quality of life, and cognition 6 months and 1 year after hematopoietic cell transplant.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(6):824-31. Abstract
Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Ceballos RM, Titus-Ernstoff L, Egan KM, Holmes MD.  2010.  Social networks and survival after breast cancer diagnosis.. Journal of cancer survivorship : research and practice. 4(4):372-80. Abstract
Bennett JM, Kaminski MS, Leonard JP, Vose JM, Zelenetz AD, Knox SJ, Horning S, Press OW, Radford JA, Kroll SM et al..  2005.  Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.. Blood. 105(12):4576-82. Abstract
Bensinger WI, Jagannath S, Vescio R, Camacho E, Wolf J, Irwin D, Capo G, McKinley M, Potts P, Vesole DH et al..  2010.  Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma.. British journal of haematology. 148(4):562-8. Abstract
Bernstein SH, Unger JM, LeBlanc M, Friedberg J, Miller TP, Fisher RI.  2009.  Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(1):114-9. Abstract
Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB et al..  2010.  Body-mass index and mortality among 1.46 million white adults.. The New England journal of medicine. 363(23):2211-9. Abstract
Bertone-Johnson ER, Powers SI, Spangler L, Larson J, Michael YL, Millen AE, Bueche MN, Salmoirago-Blotcher E, Wassertheil-Smoller S, Brunner RL et al..  2012.  Vitamin D supplementation and depression in the women's health initiative calcium and vitamin D trial.. American journal of epidemiology. 176(1):1-13. Abstract
Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P et al..  1995.  T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.. Science (New York, N.Y.). 270(5235):475-80. Abstract
Blanke CD, Rankin C, Demetri GD, Ryan CW, von Mehren M, Benjamin RS, Raymond KA, Bramwell VHC, Baker LH, Maki RG et al..  2008.  Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(4):626-32. Abstract
Boeckh MJ, Nichols GW, Chemaly RF, Papanicolaou GA, Wingard JR, Xie H, Syrjala KL, Flowers MED, Stevens-Ayers T, Jerome KR et al..  2015.  Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial.. Annals of internal medicine. 162(1):1-10. Abstract
Bray PF, Larson JC, LaCroix AZ, Manson J, Limacher MC, Rossouw JE, Lasser NL, Lawson WE, Stefanick ML, Langer RD et al..  2008.  Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events.. The American journal of cardiology. 101(11):1599-1605. Abstract
Bricker JB, Otten R, Liu JL, Peterson AV.  2009.  Parents who quit smoking and their adult children's smoking cessation: a 20-year follow-up study.. Addiction (Abingdon, England). 104(6):1036-42. Abstract
Brown ER, Otieno P, Mbori-Ngacha DA, Farquhar C, Obimbo EM, Nduati R, Overbaugh J, John-Stewart GC.  2009.  Comparison of CD4 cell count, viral load, and other markers for the prediction of mortality among HIV-1-infected Kenyan pregnant women.. The Journal of infectious diseases. 199(9):1292-300. Abstract
Buchegger F, Antonescu C, Helg C, Kosinski M, Prior JO, Delaloye AB, Press OW, Ketterer N.  2011.  Six of 12 relapsed or refractory indolent lymphoma patients treated 10 years ago with 131I-tositumomab remain in complete remission.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 52(6):896-900. Abstract